Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntingtons Disease and Establishes Clinical Advisory Board
HRN001 is a potent and specific antisense oligonucleotide designed to drive controlled…
Harness Wind Power and Smart Tech: BTC Miner Enables Passive Crypto Earnings
New York City, NY, July 05, 2025 (GLOBE NEWSWIRE) -- With the…
